Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis

The 2019 novel coronavirus (COVID-19) pandemic has placed a significant strain on hepatitis programs and interventions (screening, diagnosis, and treatment) at a critical moment in the context of hepatitis C virus (HCV) elimination. We sought to quantify changes in Direct Acting Antiviral (DAA) util...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakeri, Ahmad, Konstantelos, Natalia, Chu, Cherry, Antoniou, Tony, Feld, Jordan, Suda, Katie J., Tadrous, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310258/
https://www.ncbi.nlm.nih.gov/pubmed/34372520
http://dx.doi.org/10.3390/v13071314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310258/
https://www.ncbi.nlm.nih.gov/pubmed/34372520
http://dx.doi.org/10.3390/v13071314

Ejemplares similares